Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a retrospective, observational study.
Chen H, Yamane T, Haruyama T, Ishihara M, Kazahari H, Sakamoto T, Tanzawa S, Honda T, Ichikawa Y, Watanabe K, Seki N. Chen H, et al. Among authors: haruyama t. Transl Cancer Res. 2023 Dec 31;12(12):3538-3546. doi: 10.21037/tcr-23-1217. Epub 2023 Dec 5. Transl Cancer Res. 2023. PMID: 38192991 Free PMC article.
Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study.
Saburi M, Okuhiro K, Yoshida N, Haruyama T, Moroga Y, Yanai Y, Itani K, Takano K, Honda S, Ono K, Iwanaga M, Sasaki H, Abe M, Kohno K, Nakayama T, Ohtsuka E, Ogata M. Saburi M, et al. Among authors: haruyama t. J Clin Exp Hematop. 2023 Sep 28;63(3):197-200. doi: 10.3960/jslrt.23015. Epub 2023 Jul 28. J Clin Exp Hematop. 2023. PMID: 37518273 Free PMC article. No abstract available.
Opioid-induced nausea and vomiting: a dexamethasone multicentre prospective study.
Takagi Y, Ota S, Yomota M, Ishihara M, Hosomi Y, Watanabe K, Honda T, Kato Y, Kawai S, Sakamoto T, Haruyama T, Aruga E, Seki N. Takagi Y, et al. Among authors: haruyama t. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e741-e742. doi: 10.1136/bmjspcare-2022-003692. BMJ Support Palliat Care. 2024. PMID: 35443972 No abstract available.
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Tanaka H, Inaba M, Haruyama T, Nakamura J, Kishikawa T, Nakashima M, Iwasa K, Fujiwara K, Kohyama T, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Ishida H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Fujimoto N, Yokoyama T, Gemba K, Tsuda T, Nakagawa H, Ono H, Shimizu T, Nakamura M, Kusumoto S, Hayashi R, Shirasaki H, Ochi N, Aoe K, Kanaji N, Kashiwabara K, Inoue H, Seki N. Tanzawa S, et al. Among authors: haruyama t. Ther Adv Med Oncol. 2021 Feb 27;13:1758835921998588. doi: 10.1177/1758835921998588. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33717228 Free PMC article.
Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Ishihara M, Ochiai R, Haruyama T, Sakamoto T, Tanzawa S, Honda T, Ota S, Ichikawa Y, Ishida T, Watanabe K, Seki N. Ishihara M, et al. Among authors: haruyama t. Transl Lung Cancer Res. 2021 Jan;10(1):221-232. doi: 10.21037/tlcr-20-777. Transl Lung Cancer Res. 2021. PMID: 33569306 Free PMC article.
247 results